Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2013
06/05/2013CN103127154A Application of Gypensapogenin A in medicines resisting aseptic inflammation
06/05/2013CN103127153A Application of Gypensapogenin B in anti-platelet aggregation medicines
06/05/2013CN103127152A Application of Gypensapogenin A in insulin secretion medicines
06/05/2013CN103127151A Application of Gypensapogenin A in medicines treating acute renal failure
06/05/2013CN103127150A Application of Gypensapogenin B in medicines preventing and treating renal insufficiency
06/05/2013CN103127149A Application of Gypensapogenin B in medicines inhibiting liver fibroblast proliferation
06/05/2013CN103127148A Application of Gypensapogenin B in vasodilator medicines
06/05/2013CN103127147A Medicine composition containing budesonide and nitric oxide synthase (NOS) inhibitor and for treating nose inflammation
06/05/2013CN103127146A Medicine composition containing mometasone furoate and nitric oxide synthase (NOS) inhibitor and for treating nose inflammation
06/05/2013CN103127145A Medicine composition containing triamcinolone acetonide acetate and nitric oxide synthase (NOS) inhibitor and for treating nose inflammation
06/05/2013CN103127144A Inhalation drug composition with ciclesonide and nitric oxide synthase (NOS) inhibitor
06/05/2013CN103127143A Inhalation drug composition with budesonide and nitric oxide synthase (NOS) inhibitor
06/05/2013CN103127142A Dermal medicine composition containing mometasone furoate and amino acid derivative
06/05/2013CN103127141A Inhalation drug composition with mometasone furoate and nitric oxide synthase (NOS) inhibitor
06/05/2013CN103127140A Compound external use drug curing psoriasis
06/05/2013CN103127139A Difluprednate topical external preparation
06/05/2013CN103127138A Halometasone preparation containing protective agent and preparation method thereof
06/05/2013CN103127137A Medicine combination with hydrocortisone butyrate and nitric oxide synthase (NOS) inhibitor and for treating skin inflammation
06/05/2013CN103127136A Skin drug composition containing methylprednisolone aceponate and amino acid
06/05/2013CN103127135A Triterpene derivative and preparation method and application
06/05/2013CN103127134A Medicine composition containing fluticasone propionate and nitric oxide synthase (NOS) inhibitor and for treating nose inflammation
06/05/2013CN103127133A Inhalation drug composition with fluticasone propionate and nitric oxide synthase (NOS) inhibitor
06/05/2013CN103127132A Dermal medicine composition containing fluticasone propionate and nitric oxide synthase (NOS) inhibitor
06/05/2013CN103127131A Solid composition with valsartan and preparation method thereof
06/05/2013CN103127130A Cefotaxime sodium pharmaceutical composition powder injection
06/05/2013CN103127129A Cefuroxime sodium pharmaceutical composition and preparation method thereof
06/05/2013CN103127128A Cefpirome sulfate pharmaceutical composition powder injection
06/05/2013CN103127127A Cefoperazone sodium pharmaceutical composition and preparation method thereof
06/05/2013CN103127126A 1-[4-[3-(4-morpholinyl)propoxy]-2-hydroxy phenyl]-3-(4-morpholinyl)-2-propylene-1-one and application thereof
06/05/2013CN103127125A Paracetamol and caffeine dry suspension and preparation method thereof
06/05/2013CN103127124A Medicine composition of selegiline and folic acid type compound and use thereof
06/05/2013CN103127123A Entacapone/folic acid compound medicine composition and application thereof
06/05/2013CN103127122A Pharmaceutical composition of levodopa/folic acid compounds and purpose thereof
06/05/2013CN103127121A Rasagiline/folic acid compound medicine combination and purpose thereof
06/05/2013CN103127120A Medicine combination of amantadine/folic acid compounds and purpose thereof
06/05/2013CN103127119A Pharmaceutical composition of piribedil/folic acid compound and purpose thereof
06/05/2013CN103127118A Medicine composition of pramipexole/ folic acid compounds and functions thereof
06/05/2013CN103127117A Pharmaceutical composition of levodopa/benserazide/folic acid compounds and purpose thereof
06/05/2013CN103127116A Carbidopa/levodopa/folic acid compound medicine composition and use thereof
06/05/2013CN103127115A Composition capable of curing abnormal blood lipid
06/05/2013CN103127114A Medicinal composition including piperacillin sodium and sulbactam sodium
06/05/2013CN103127113A Compound pseudoe-phedrine hydro-chloride dry suspension and preparation method thereof
06/05/2013CN103127112A Application of quinolinone derivatives in tumor treatment
06/05/2013CN103127111A Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore
06/05/2013CN103127110A Compound preparation containing angiotensin II receptor antagonist and calcium channel blocker
06/05/2013CN103127109A Pharmaceutical composition containing dabigatran etexilate or salt and hydrate thereof
06/05/2013CN103127108A Telmisartan amlodipine tablet, and preparation method and use thereof
06/05/2013CN103127107A Application of levamlodipine or and salts thereof to treatment of liver cancer
06/05/2013CN103127106A Purpose of phencynonate hydrochloride for treating or relieving myocardial damage induced by myocardial ischemia reperfusion and pharmaceutical compositions including phencynonate hydrochloride
06/05/2013CN103127105A Rhynchophylline application in drug preparing for preventing inflammation caused by excessive activation of astrocytes
06/05/2013CN103127104A Application of oxymatrine in anti-tumor drug preparation
06/05/2013CN103127103A Application of sophoridine in anti-tumor drug preparation
06/05/2013CN103127102A Application of 8-propyl dicyan berberine in preparation of antitumor drug
06/05/2013CN103127101A Application of 8-diethyl malonate berberine in preparation of antitumor drug
06/05/2013CN103127100A Formulation and method for vascular permeability-related diseases or conditions
06/05/2013CN103127099A Amoxicillin potassium clavulanate dry suspension and production process thereof
06/05/2013CN103127098A Anti-cancer pharmaceutical composition containing clavulanic acid or salts thereof and pharmaceutical application
06/05/2013CN103127097A Ertapenem pharmaceutical composition
06/05/2013CN103127096A Application of pyrryl-substituted indole compound in curing glaucoma
06/05/2013CN103127095A Synthesis and application of dihydrothiophenone derivative as pfDHODH inhibitor
06/05/2013CN103127094A Application of arctigenin in preparation of medicine for curing viral hepatitis type b
06/05/2013CN103127093A Application of arctigenin in preparation of medicine for curing or preventing brain glioma
06/05/2013CN103127092A Application of Aphanamixoid A to medicine for treating osteoporosis caused by antiestrogen insufficiency
06/05/2013CN103127091A Application of Aphanamixoid A in medicines curing colorectal cancer
06/05/2013CN103127090A Application of Aphanamixoid A in medicines curing kidney cancer
06/05/2013CN103127089A Application of Eryngiolide A in medicines curing or preventing kidney fibrosis
06/05/2013CN103127088A Application of Eryngiolide A in medicines treating ischemic cerebral damage
06/05/2013CN103127087A Application of Aphanamixoid A in medicines curing acute gout
06/05/2013CN103127086A Application of Eryngiolide A in medicines curing or preventing dental ulcer
06/05/2013CN103127085A Application of Eryngiolide A in medicines treating chronic obstructive pulmonary disease
06/05/2013CN103127084A Application of Aphanamixoid A to platelet increasing medicine
06/05/2013CN103127083A Application of Aphanamixoid A to insulin secretion stimulating medicine
06/05/2013CN103127082A Application of Eryngiolide A in medicines treating hemorrhage fever with renal syndrome
06/05/2013CN103127081A Application of Aphanamixoid A to leukocyte increasing medicine
06/05/2013CN103127080A Application of Aphanamixoid A in medicines curing skin cancer
06/05/2013CN103127079A Application of Aphanamixoid A in medicines curing stomach cancer
06/05/2013CN103127078A Application of Aphanamixoid A to rhinitis treatment medicine
06/05/2013CN103127077A Application of Aphanamixoid A to dental ulcer treatment or prevention medicine
06/05/2013CN103127076A Application of Aphanamixoid A to lung cancer treatment medicine
06/05/2013CN103127075A Application of Aphanamixoid A to aseptic inflammation resistance medicine
06/05/2013CN103127074A Application of Aphanamixoid A to ileocecum cancer treatment medicine
06/05/2013CN103127073A Application of Eryngiolide A in anti-platelet aggregation medicines
06/05/2013CN103127072A Application of Eryngiolide A in medicines curing yellow fever virus infection
06/05/2013CN103127071A Application of Eryngiolide A in medicines curing Alzheimer disease
06/05/2013CN103127070A Application of Eryngiolide A in medicines rising white blood cell
06/05/2013CN103127069A Application of Eryngiolide A in medicines treating acute renal failure
06/05/2013CN103127068A Application of Eryngiolide A in medicines promoting insulin secretion
06/05/2013CN103127067A Application of Eryngiolide A in antibacterial medicines
06/05/2013CN103127066A Application of Eryngiolide A in medicines curing rarefaction of bone caused by lack of antiestrogen
06/05/2013CN103127065A Application of Eryngiolide A in medicines reducing blood sugar
06/05/2013CN103127064A Application of Eryngiolide A in respiratory syncytial virus medicines
06/05/2013CN103127063A Application of chloranthus japonicus alcohol F in preparation of antitumor drugs
06/05/2013CN103127062A Application of 13'-acetyl silver grass alcohol C in manufacturing of antineoplastic drugs
06/05/2013CN103127061A Medicine application of chloranthus japonicus alcohol M
06/05/2013CN103127060A Application of chloranthus japonicus alcohol D in preparation of antitumor drugs
06/05/2013CN103127059A Oral administration preparation composed of bilobalide B derivative and preparation method thereof
06/05/2013CN103127058A Moxidectin preparation and preparing method thereof
06/05/2013CN103127057A Application of fraxinellone in preparing of antineoplastic medicines
06/05/2013CN103127056A Application of psoromic acid in anti-tumor drug preparation
06/05/2013CN103127055A Application of tangeretin serving as sensitizer used for preparing chemotherapeutics used for curing solid tumor
1 ... 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 ... 7860